A new product development project $($ research and development $)$ ?uses a "phase gate" project review process to evaluate the ongoing potential for a possible new product, similar to other products we produce. The product is a drug $/$ ?pharmaceutical that might be utilized in life $-$ saving circumstances, available $"$ by prescription only". You are one of the key project sponsors for this project, and you are attending a phase $-$ gate meeting, to decide if the project should continue, or be discontinued. Key information includes:

If the project is discontinued, it is likely that key researchers will be reassigned to other projects, and the research $-$ to $-$ date could be saved and restarted at a later time.

If the project is successful, the drug has an estimated market revenue potential of $ $50$ ?million per year for $10$ ?years. The cutting $-$ edge nature of the project means that the probability of success $($ or failure $)$ ?is moderate but unknown.

Sunk $-$ costs to date include a two $-$ year time commitment and $ $100$ ?million $($ $ $50$ ?million per year, for two years $)$

The lead researcher continues to remain uncertain $($ either way $)$ ?if the project will be successful or not

Compare and contrast a $)$ ?the reasons to continue the project vs $.$ ?b $)$ ?the reasons to discontinue the project. c $)$ ?What would be your final recommendation? and d $)$ ?explain why